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A short calving to conception interval is of main importance to
achieve high economic eﬃciency in dairy cow industry. In
order to reduce this interval, several hormonal treatments have
been put on the market, in which cloprostenol, a synthetic
analogue of prostaglandin F2a (PGF2a). The aim of this study
was to compare fertility of cloprostenol-induced oestrus to that
of spontaneous oestrus in dairy cows. In a group of 525 cows,
280 (treated group) were administered 0.5 mg cloprostenol i.m.
after transrectal corpus luteum (CL) detection, and insemin-
ated at detected oestrus during the following week. The other
245 cows (control group) were inseminated during sponta-
neous oestrus. Whey progesterone concentrations were
checked at treatment and at insemination in order to remove
from the study cows whose P4 levels indicate a non-functional
CL, or a lack of luteolysis respectively. Moreover, cows that
were not inseminated due to genital problems were also
excluded from this study. Conception (59% vs 54.5%) and
calving rates (93.7% vs 93%) were not signiﬁcantly diﬀerent
between the two groups.
Introduction
The early resumption of normal cyclicity during the
postpartum period is essential in order to obtain a high
reproductive eﬃciency in dairy cow industry. To keep the
calving interval under 365 days, cows have to be preg-
nant not later than 80–85 days postpartum. A delay in
ﬁrst ovulation or in ﬁrst oestrus occurrence/detection is
related with a lower conception rate (CR) and a longer
calving to conception interval. In fact, cows that had at
least one oestrus before insemination showed better
fertility compared with cows inseminated at the ﬁrst
postpartum oestrus (Rhodes et al. 2003). Moreover,
cows not observed in oestrus up to 60 days postpartum
have a signiﬁcantly higher risk of being culled (Opsomer
et al. 2000a), because in high-yielding and medium-
yielding herds it can be proﬁtable to reduce the number
of animals with a long calving to conception interval
(Esslemont et al. 2001). The percentage of cows with a
prolonged postpartum anoestrus due to lack of ovulation
within 44 days after calving (Lamming and Darwash
1998) is approximately 11–13% in the UK (Royal et al.
2000). In North America, the percentage of cows that are
still in anoestrus 60 or more days after parturition varies
between 23% (Moreira et al. 2001) and 38% (Lucy
2001). In Belgium, 22% of the cows do not ovulate within
50 days postpartum (Opsomer et al. 2000b).
The problem of prolonged postpartum anoestrus in
dairy cows can be solved improving management or by
using hormonal treatments. The aim of those treatments
was to stimulate follicular development to induce
oestrus and ovulation in cases of anovulatory anoestrus,
and to induce luteolysis in cows not detected in oestrus,
but with a detectable corpus luteum (CL) (Rhodes et al.
2003).
Prostaglandin F2a (PGF2a) is a luteolytic substance
commonly used in cattle as it can induce CL regression
and fertile oestrus within 3–5 days after treatment
(Inskeep 1973). For years PGF2a has been used in many
protocols for induction or synchronization of oestrus,
both as a single drug or in association with other
hormones (Xu et al. 1997; Lopez-Gatius 2000; Diskin
et al. 2002; Richardson et al. 2002; Taponen et al. 2002;
Thatcher et al. 2002; Yaniz et al. 2004). On the contrary,
Pursley et al. (1997) showed that PGF2a administration
does not result in an accurate oestrus/ovulation syn-
chronization. These diﬀerences in treatment eﬃciency
might be due to the fact that the PGF2a was not
administered at the same time during the cycle, resulting
in a diﬀerent follicular development (Kastelic et al. 1990).
The hypothesis explaining the low eﬃcacy of PGF2a
in the ﬁrst days of diestrus due to the lack of speciﬁc
receptors during this phase was confuted years ago
(Wiltbank et al. 1995). The mechanism of luteolysis
seems to have a much more complex regulation, passing
through gene expression modulating steroidogenesis,
apoptosis, immune reaction and even the production of
PGF2a from the CL itself, together with structural and
enzymatic modiﬁcation of the luteal cells (Tsai and
Wiltbank 1998). The neuroendocrine, paracrine and
autocrine mechanisms involved in luteolysis regulation
and PGF2a action are still not completely understood
(Skarzynski et al. 2000).
In relation to PGF2a-induced oestrus fertility, a
retrospective study byMcIntosh et al. (1984) highlighted
the diﬀerences between the results reported by several
authors, as well as the diﬃculty in comparing results due
to the extreme variability of the experimental designs.
Studies concerning the relationship between PGF2a-
induced oestrus and fertility have also been presented
in more recent studies, with some of them reporting
positive or absent eﬀect (Pankowski et al. 1995) and
others ﬁnding negative eﬀects (Xu et al. 1997).
Treatments of lactating dairy cows aiming at oestrous
cycle control often provide unsatisfactory results, par-
ticularly in animals with high genetic value. This fact is
presumed to be related to the typical low fertility of
those animals, linked to the increasing selective pressure
for high milk yield (Lucy 2001), but also to the negative
energy balance (Butler 2002) and to an abnormal
ovarian activity during the ﬁrst part of lactation.
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Notwithstanding their increasing diﬀusion, treatments
for oestrus synchronization are being debated once
more, and a change in the results of PGF2a administra-
tion is supposed to be connected to the intense selective
pressure of the last years (Macmillan et al. 2003).
Therefore, the aim of this study was to evaluate
fertility diﬀerences between cloprostenol-induced and
spontaneous oestrus in dairy cows at the ﬁrst postpar-
tum artiﬁcial insemination (AI).
Materials and Methods
Animals
The research was carried out over a 3-year period on 525
cows from two Italian Friesian cow herds (herd A ¼ 290
cows and herd B ¼ 235 cows), located in northern Italy
and characterized by 8850 kg/cow milk yield (3.95% fat,
3.48% proteins) and 8540 kg/cow (3.9% fat, 3.5%
proteins) respectively. The cows were fed with a
balanced diet formulated in accordance with the Nutri-
ent Requirements of Dairy Cattle (2001).
Cows were clinically healthy, with normal cyclicity
and in good body condition (BCS ¼ 2.7–3), one to six
parity, not yet inseminated 60 days after calving.
On a total of 525 subjects, 280 cows (160 from herd A
and 120 from herd B), were included in the group of
treatment, while the remaining 245 animals (130 belong-
ing to herd A and 115 to herd B) were used as control
group.
Treated group
The 280 treated cows were administered i.m. with
0.5 mg of cloprostenol (Estrumate, Mallinckrodt,
Verona, Italy), a synthetic analogue of PGF2a when a
mature CL (identiﬁed on the basis of size, liver-like
consistency, and the most likely presence of a basal
stricture and ovulatory papilla) was transrectally clinic-
ally detected. During the week after treatment, animals
were checked twice a day for oestrus detection. The
cows showing oestrus, with a pre-ovulatory follicle and
normal condition of genital tract (uterine tone, cervical
mucus) were submitted to AI 12 h after the beginning of
oestrus with semen of proven fertility.
Control group
The 245 control cows were submitted to the same
diagnostic procedures, aimed at conﬁrming the presence
of feasible conditions for AI, at oestrus detection.
Evening milk samples were collected on the day of
cloprostenol administration to evaluate the activity of
the CL, as well as on the day of oestrus to verify the
occurrence of luteolysis in the treated subjects and the
absence of luteal activity in all inseminated animals
(both treated and control cows).
Hormonal analysis
Progesterone (P4) levels in whey were measured by
radioimmunoassay (RIA) using the technique described
by Prandi et al. (1992). Intra-assay and interassay
coeﬃcients of variation (CV) were 8.9% and 7.6% for
diestral values and 18.6% and 18.3% for estral values
respectively. On the basis of luteal activity, the CL was
considered to be functional when P4 concentrations
were >382 pmol/L and absent when P4 concentrations
were <318 pmol/L (Prandi et al. 1994).
Fertility analysis
Fertility was evaluated by pregnancy diagnosis through
palpation per rectum 7 weeks after AI and further
conﬁrmed at calving.
Conception rate (pregnant cows/inseminated cows)
and calving rate (calvings/pregnant cows) were evalu-
ated for signiﬁcance using chi-square test. Statistical
signiﬁcance was set at p < 0.05.
Results
Treated group
Of the 280 cows treated following the clinical ﬁnding of
a mature CL, 230 (82.1%) showed signs of oestrus
within 7 days of the closprostenol administration: 134 of
160 (83.8%) from herd A and 96 of 120 (80%) from
herd B. Most induced oestruses (95%) were detected
between 3 and 5 days post-treatment, with the highest
frequency (57%) on the fourth day.
Whey progesterone analysis detected 207 of 280
(73.9%; herd A ¼ 74.4%, herd B ¼ 73.3%) cows with
diestral P4 levels (398–2862 pmol/L) on the day of
cloprostenol treatment, as an evidence of functional CL
presence: 119 of 160 (74.4%) from herd A and 88 of 120
(73.3%) from herd B.
The results of diagnosis of cows with clinical-detected
mature CL, on the basis of whey P4 concentration
measured on the day of treatment, are reported in
Table 1.
Luteolysis, as evidenced by progesterone concentra-
tions <318 pmol/L (range: 32–302), was seen in 175 of
207 (84.5%) cows, 97 of 119 (81.5%) from herd A and
78 of 88 (88.6%) from herd B.
Only 161 of 175 (92%) cows with cloprostenol-
induced oestrus were submitted to AI, as 14 (herd
A ¼ 9, herd B ¼ 5) did not show genital tract condi-
tions suitable for AI.
Control group
Of the 245 cows from control group with spontaneous
oestrus, 220 (89.8%) showed whey P4 levels (35–
308 pmol/L) consistent with oestrus (P4: <318 pmol/L)
on the day of AI: 120 of 130 (92.3%) and 100 of 115
(87%) belonging to herd A and B respectively
(Table 2).
Table 1. Diagnosis of 280 cloprostenol-treated cows with clinical-
detected mature corpus luteum (CL) on the basis of whey P4 levels
Herd A Herd B Total
Mature CL (clinical ﬁnding) 160 120 280
Functional CL (P4: >382 pmol/L) 119 88 207
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Only 209 of 220 (95%) non-treated cows were submit-
ted to AI, as 11 animals (herd A ¼ 6, herd B ¼ 5)
did not show genital tract conditions suitable for AI.
Fertility analysis
The fertility data of cows with cloprostenol-induced
oestrus and spontaneous oestrus submitted to AI with
whey P4 concentrations <318 pmol/L are presented in
Table 3.
The frequency analyses pertaining to the considered
fertility index (pregnancy and calving rates) were eval-
uated with chi-square test, both from the data of the two
herds considered separately and together, and no
signiﬁcant diﬀerence was found between cows with
cloprostenol-induced and spontaneous oestrus.
Discussion
During the postpartum period it is very common to use
the PGF2a with the aim of shortening the diestrus phase
or synchronizing oestruses in order to avoid decrease of
reproductive eﬃciency and the subsequent reduction of
herd proﬁtability. For this reason, the comparison
between cloprostenol-induced and spontaneous oestrus
fertility was assessed.
In the attempt to reduce as much as possible the
interference of factors not directly connected with the
fertility of oestrus, precise clinical restrictions were
enforced. First, despite the clinical ﬁnding of a mature
CL, cows with whey P4 levels (<382 pmol/L) inconsis-
tent with a functional CL (26.1%), were removed from
the analysis of fertility.
In this study the accuracy of per rectum palpation
for the presence of a functional CL was 73.9%,
conﬁrming the unreliability of rectal palpation alone
to assess the CL functionality, in agreement with
ﬁndings previously reported by other authors (Ott
et al. 1986; Kelton et al. 1991; Archbald et al. 1993;
Hanzen et al. 2000).
This justify the use of whey P4 RIA concentrations
which increased the precision of the diagnosis. The
luteolytic eﬃciency (84.5%), obtained with a single
cloprostenol administration, was evaluated not only on
the basis of oestrus signs observation, but also by the
actual oestrus induction following a drop of whey P4
levels to values lower than 318 pmol/L. It is diﬃcult to
compare this ﬁnding with the oestrous response rates to
PGF2a selection treatments (55% and 78.2%) reported
by Archbald et al. (1994) and Xu et al. (1997), respect-
ively, because of diﬀerent experimental designs.
A 10.2% of the cows showing spontaneous oestrus
have been excluded from the control group as well,
because they did not present P4 values <318 pmol/L,
indeed, the mean P4 of cows in oestrus is under 318 pM
but for some individuals the P4 during oestrus can be
higher because of a luteolysis still not completed. In
order to avoid errors, cows with P4 higher than
318 pmol/L were excluded from the experiment even if
they were showing oestrus.
Furthermore, it should be noted that the 6.8% of the
cows (8.7% of the treated vs 5.3% of the control group,
n.s.), which were really showing oestrus, were not
submitted to AI because of non-optimal genital tract
conditions.
Hence, the fertility of 161 cows in which oestrus was
induced by a single administration of 0.5 mg cloproste-
nol was compared with that of 209 whose oestrus was
spontaneous. Neither pregnancy rate (59% vs 54.5%)
nor calving rate (93.7% vs 93%) showed signiﬁcant
diﬀerences. As well, no diﬀerences were found between
the two farms in which the study was carried out. These
results conﬁrm our previous ﬁndings (Veronesi et al.
1996; Battocchio et al. 2000) obtained under the same
experimental conditions. In fact, Veronesi et al. (1996)
reported no signiﬁcantly diﬀerent pregnancy rates
(43.6% vs 52.1%) between cows with cloprostenol-
induced oestrus and spontaneous oestrus respectively.
Similarly, Battocchio et al. (2000) found pregnancy
rates of 42.7% vs 51.5% (n.s.) in cloprostenol-induced
oestrus and spontaneous oestrus respectively.
The rate of pregnancy loss was not signiﬁcantly
diﬀerent between cloprostenol-treated (6.3%) and con-
trol group (7%) cows. Even if these values are a bit
higher than optimal threshold (<5%; Upham 1991),
they should be considered as ranging in the actual mean
values (7–18%; David et al. 1971; Cavalieri et al. 2003).
In conclusion, data from this study showed the
absence of signiﬁcant diﬀerences concerning pregnancy
and calving rates after the ﬁrst AI performed at least
60 days postpartum, between cows with cloprostenol-
induced and spontaneous oestrus.
The reduction of fertility of PGF2a-induced oestrus
compared with spontaneous oestrus, reported by sev-
eral practitioners, could be related to the simple
evaluation of pregnant/treated cows, without taking
into account diagnostic errors. In fact, in the present
study, the diagnostic errors implied the exclusion of
42.5% treated cows and only 14.7% control cows
during the subsequent steps of animal selection: PGF2a
Table 2. Cows with spontaneous oestrus compared with their whey P4
levels
Herd A Herd B Total
Oestrus (clinical detection) 130 115 245
Oestrus (P4: <318 pmol/L) 120 100 220
Table 3. Conception and calving
rates in cows with cloprostenol-
induced and spontaneous oestrus
Herd A Herd B Total
Treated Control Treated Control Treated Control
Inseminated 88 114 73 95 161 209
Pregnant 52 (59.1%) 61 (53.5%) 43 (58.9%) 53 (55.8%) 95 (59%) 114 (54.5%)
Calving 49 (94.2%) 57 (93.4%) 40 (93%) 49 (92.5%) 89 (93.7%) 106 (93%)
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CL sensitivity, luteolysis, hormonal levels and genital
tract conditions.
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